Stem cell transplantation for amyotrophic lateral sclerosis: Therapeutic potential and perspectives on clinical translation

Cellular and Molecular Life Sciences

Volumn 71, Issue 17, 2014, Pages 3257-3268

  Faravelli, Irene ^a   Riboldi, Giulietta ^a   Nizzardo, Monica ^a   Simone, Chiara ^a   Zanetta, Chiara ^a   Bresolin, Nereo ^a   Comi, Giacomo P ^a   Corti, Stefania ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Amyotrophic lateral sclerosis; Clinical translation; Stem cells; Transplantation

Indexed keywords

ALDEHYDE DEHYDROGENASE; BRAIN DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; OLANZAPINE; OZANEZUMAB; SOMATOMEDIN C; VASCULOTROPIN;

AMYOTROPHIC LATERAL SCLEROSIS; AUTOLOGOUS BONE MARROW TRANSPLANTATION; AUTOLOGOUS STEM CELL TRANSPLANTATION; BLOOD BRAIN BARRIER; DRUG EFFICACY; DRUG SAFETY; ENZYME ACTIVITY; HUMAN; IMMUNOGENICITY; LIPID DIET; MESENCHYMAL STEM CELL TRANSPLANTATION; MINIMALLY INVASIVE PROCEDURE; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PLURIPOTENT STEM CELL; PROSPECTIVE STUDY; REVIEW; STEM CELL TRANSPLANTATION;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CELLULAR MICROENVIRONMENT; CLINICAL TRIALS AS TOPIC; DISEASE MODELS, ANIMAL; EMBRYONIC STEM CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; INJECTIONS, SPINAL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOTOR NEURONS; NEURAL STEM CELLS; NEUROGENESIS; NEUROGLIA; SPINAL CORD; STEM CELL TRANSPLANTATION; THERAPIES, INVESTIGATIONAL; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84906226651     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-014-1613-4     Document Type: Review

References (55)

1. Robberecht W, Philips T (2013) The changing scene of amyotrophic lateral sclerosis. Nat Rev Neurosci 14:248-264
2. Gordon P, Corcia P, Meininger V (2013) New therapy options for amyotrophic lateral sclerosis. Expert Opin Pharmacother 14:1907-1917
3. Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A et al (2011) Amyotrophic lateral sclerosis. Lancet 377:942-955
4. Ilieva H, Polymenidou M, Cleveland DW (2009) Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J Cell Biol 187:761-772
5. Rothstein JD (2009) Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann Neurol 65(Suppl 1):S3-S9
6. Yang W, Strong MJ (2012) Widespread neuronal and glial hyperphosphorylated tau deposition in ALS with cognitive impairment. Amyotroph Lateral Scler 13:178-193
7. Miller RG, Mitchell JD, Moore DH (2012) Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst Rev 3:CD001447
8. Dupuis L, Gonzalez de Aguilar JL, Echaniz-Laguna A, Eschbach J, Rene F (2009) Muscle mitochondrial uncoupling dismantles neuromuscular junction and triggers distal degeneration of motor neurons. PLoS One 4:e5390
9. Nizzardo M, Simone C, Falcone M, Riboldi G, Rizzo F et al (2012) Research advances in gene therapy approaches for the treatment of amyotrophic lateral sclerosis. Cell Mol Life Sci 69:1641-1650
10. Boulis NM, Federici T, Glass JD, Lunn JS, Sakowski SA et al (2011) Translational stem cell therapy for amyotrophic lateral sclerosis. Nat Rev Neurol 8:172-176
11. Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676 (Pubitemid 44233629)
12. Takahashi K, Okita K, Nakagawa M, Yamanaka S (2007) Induction of pluripotent stem cells from fibroblast cultures. Nat Protoc 2:3081-3089
13. Corti S, Locatelli F, Papadimitriou D, Donadoni C, Del Bo R et al (2006) Transplanted ALDHhiSSClo neural stem cells generate motor neurons and delay disease progression of nmd mice, an animal model of SMARD1. Hum Mol Genet 15:167-187 (Pubitemid 43125973)
14. Corti S, Locatelli F, Papadimitriou D, Del Bo R, Nizzardo M et al (2007) Neural stem cells LewisX+ CXCR4+ modify disease progression in an amyotrophic lateral sclerosis model. Brain 130:1289-1305 (Pubitemid 47355948)
15. Nizzardo M, Simone C, Rizzo F, Ruggieri M, Salani S, et al (2014) Minimally invasive transplantation of iPSC-derived ALD-HhiSSCloVLA4+ neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis model. Hum Mol Genet 23:342-354
16. Corti S, Nizzardo M, Nardini M, Donadoni C, Salani S et al (2008) Neural stem cell transplantation can ameliorate the phenotype of a mouse model of spinal muscular atrophy. J Clin Invest 118:3316-3330
17. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N et al (2004) Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10:858-864 (Pubitemid 39070860)
18. Imitola J, Raddassi K, Park KI, Mueller FJ, Nieto M et al (2004) Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1α/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci USA 101:18117-18122 (Pubitemid 40054083)
19. Wyatt TJ, Rossi SL, Siegenthaler MM, Frame J, Robles R et al (2011) Human motor neuron progenitor transplantation leads to endogenous neuronal sparing in three models of motor neuron loss. Stem Cells Int 2011:207230
20. Erceg S, Ronaghi M, Oria M, Rosello MG, Arago MA et al (2010) Transplanted oligodendrocytes and motoneuron progenitors generated from human embryonic stem cells promote locomotor recovery after spinal cord transection. Stem Cells 28:1541-1549
21. Valori CF, Brambilla L, Martorana F, Rossi D (2014) The multifaceted role of glial cells in amyotrophic lateral sclerosis. Cell Mol Life Sci 71:287-297
22. Boucherie C, Schafer S, Lavand'homme P, Maloteaux JM, Hermans E (2009) Chimerization of astroglial population in the lumbar spinal cord after mesenchymal stem cell transplantation prolongs survival in a rat model of amyotrophic lateral sclerosis. J Neurosci Res 87:2034-2046
23. Lepore AC, Rauck B, Dejea C, Pardo AC, Rao MS et al (2008) Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease. Nat Neurosci 11:1294-1301
24. Suzuki M, McHugh J, Tork C, Shelley B, Hayes A et al (2008) Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS. Mol Ther 16:2002-2010
25. Lunn JS, Sakowski SA, Federici T, Glass JD, Boulis NM et al (2011) Stem cell technology for the study and treatment of motor neuron diseases. Regen Med 6:201-213
26. Borlongan CV (2012) Recent preclinical evidence advancing cell therapy for Alzheimer's disease. Exp Neurol 237:142-146
27. Lee ST, Chu K, Jung KH, Kim SJ, Kim DH et al (2008) Anti-inflammatory mechanism of intravascular neural stem cell transplantation in haemorrhagic stroke. Brain 131:616-629 (Pubitemid 351294711)
28. Lindvall O, Kokaia Z (2006) Stem cells for the treatment of neurological disorders. Nature 441:1094-1096 (Pubitemid 43990722)
29. Corti S, Nizzardo M, Nardini M, Donadoni C, Salani S et al (2010) Systemic transplantation of c-kit+ cells exerts a therapeutic effect in a model of amyotrophic lateral sclerosis. Hum Mol Genet 19:3782-3796
30. Kerr DA, Llado J, Shamblott MJ, Maragakis NJ, Irani DN et al (2003) Human embryonic germ cell derivatives facilitate motor recovery of rats with diffuse motor neuron injury. J Neurosci 23:5131-5140 (Pubitemid 36793241)
31. Klein SM, Behrstock S, McHugh J, Hoffmann K, Wallace K et al (2005) GDNF delivery using human neural progenitor cells in a rat model of ALS. Hum Gene Ther 16:509-521 (Pubitemid 40647148)
32. Mitrecic D, Nicaise C, Gajovic S, Pochet R (2010) Distribution, differentiation, and survival of intravenously administered neural stem cells in a rat model of amyotrophic lateral sclerosis. Cell Transpl 19:537-548
33. Teng YD, Benn SC, Kalkanis SN, Shefner JM, Onario RC et al (2012) Multimodal actions of neural stem cells in a mouse model of ALS: a meta-analysis. Sci Transl Med 4:165ra164
34. Sandoe J, Eggan K (2013) Opportunities and challenges of pluripotent stem cell neurodegenerative disease models. Nat Neurosci 16:780-789
35. Han SS, Williams LA, Eggan KC (2011) Constructing and deconstructing stem cell models of neurological disease. Neuron 70:626-644
36. Madhavan L, Collier TJ (2010) A synergistic approach for neural repair: cell transplantation and induction of endogenous precursor cell activity. Neuropharmacology 58:835-844
37. Chu K, Kim M, Jeong SW, Kim SU, Yoon BW (2003) Human neural stem cells can migrate, differentiate, and integrate after intravenous transplantation in adult rats with transient forebrain ischemia. Neurosci Lett 343:129-133 (Pubitemid 36577532)
38. Kim SU, de Vellis J (2009) Stem cell-based cell therapy in neurological diseases: a review. J Neurosci Res 87:2183-2200
39. Jeong SW, Chu K, Jung KH, Kim SU, Kim M et al (2003) Human neural stem cell transplantation promotes functional recovery in rats with experimental intracerebral hemorrhage. Stroke 34:2258-2263 (Pubitemid 37099846)
40. Pluchino S, Cossetti C (2013) How stem cells speak with host immune cells in inflammatory brain diseases. Glia 61:1379-1401
41. Pluchino S, Zanotti L, Deleidi M, Martino G (2005) Neural stem cells and their use as therapeutic tool in neurological disorders. Brain Res Brain Res Rev 48:211-219 (Pubitemid 40585752)
42. Winkler EA, Sengillo JD, Sullivan JS, Henkel JS, Appel SH et al (2013) Blood-spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis. Acta Neuropathol 125:111-120
43. D'Amico E, Factor-Litvak P, Santella RM, Mitsumoto H (2013) Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis. Free Radic Biol Med 65C:509-527
44. Steinman L (2009) A molecular trio in relapse and remission in multiple sclerosis. Nat Rev Immunol 9:440-447
45. Mazzini L, Ferrero I, Luparello V, Rustichelli D, Gunetti M et al (2010) Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: a phase I clinical trial. Exp Neurol 223:229-237
46. Martinez HR, Gonzalez-Garza MT, Moreno-Cuevas JE, Caro E, Gutierrez-Jimenez E et al (2009) Stem-cell transplantation into the frontal motor cortex in amyotrophic lateral sclerosis patients. Cytotherapy 11:26-34
47. Karussis D, Karageorgiou C, Vaknin-Dembinsky A, Gowda-Kurkalli B, Gomori JM et al (2010) Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch Neurol 67:1187-1194
48. Cashman N, Tan LY, Krieger C, Madler B, Mackay A et al (2008) Pilot study of granulocyte colony stimulating factor (G-CSF)-mobilized peripheral blood stem cells in amyotrophic lateral sclerosis (ALS). Muscle Nerve 37:620-625 (Pubitemid 351590553)
49. Chio A, Mora G, La Bella V, Caponnetto C, Mancardi G et al (2011) Repeated courses of granulocyte colony-stimulating factor in amyotrophic lateral sclerosis: clinical and biological results from a prospective multicenter study. Muscle Nerve 43:189-195
50. Riley J, Glass J, Feldman EL, Polak M, Bordeau J, et al (2014) Intraspinal stem cell transplantation in ALS: a phase I trial, cervical microinjection and final surgical safety outcomes. Neurosurgery 74:77-87
51. Gordon JR, Ma Y, Churchman L, Gordon SA, Dawicki W (2014) Regulatory dendritic cells for immunotherapy in immunologic diseases. Front Immunol 5:7
52. Scheiner ZS, Talib S, Feigal EG (2014) The potential for immunogenicity of autologous induced pluripotent stem cell-derived therapies. J Biol Chem 289:4571-4577
53. Miyazaki S, Yamamoto H, Miyoshi N, Takahashi H, Suzuki Y et al (2012) Emerging methods for preparing iPS cells. Jpn J Clin Oncol 42:773-779
54. Lister R, Pelizzola M, Kida YS, Hawkins RD, Nery JR et al (2011) Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 471:68-73
55. Nizzardo M, Simone C, Falcone M, Locatelli F, Riboldi G et al (2010) Human motor neuron generation from embryonic stem cells and induced pluripotent stem cells. Cell Mol Life Sci 67:3837-3847